相关实验视频

Updated: Jun 15, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

如何找到片段:在基于片段的药物发现中选和验证的方法

Tim Kirkman¹, Catharina Dos Santos Silva², Manuela Tosin¹

¹Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK.

|August 28, 2024

概括

基于碎片的药物发现 (FBDD) 通过选小型化合物库,为新药开发提供了一种强大的方法. 本综述详细介绍了碎片查和验证的常见生物物理技术.

科学领域:

药用化学医学化学
药物发现药物发现药物发现
生物物理学的生物物理.

背景情况:

基于碎片的药物发现 (FBDD) 是开发针对癌症和传染病等疾病的新疗法的一个成功策略.
在过去的二十年中,FBDD在学术研究和制药行业都获得了显著的引力,至少有七种销售的药物证明了这一点.
该FBDD方法使用选的小,低分子量化合物 (大约. 300 Da) 来自1000-2000个分子的图书馆.

研究的目的:

审查用于碎片查的常见生物物理技术.
讨论碎片选中的直角验证方法.
探索与FBDD中各种生物物理技术相关的优点,缺点,应用和战略.

主要方法:

审查的重点是总结用于碎片查的广泛使用的生物物理方法.
它包括用于识别碎片的直角验证的技术.
讨论包括对不同生物物理方法的比较分析.

主要成果:

与使用更大的化合物库进行高通量选相比,FBDD可以更好地探索化学空间和多样性.
各种生物物理技术适用于碎片选,每个都有特定的优点和局限性.
该审查提供了FBDD应用的例子和战略考虑.

结论:

生物物理技术对于药物发现中的有效碎片选至关重要.
了解每个技术的优缺点有助于优化FBDD策略.
FBDD仍然是识别新药候选药物的有价值和不断发展的方法.

关键词:

生物物理方法生物物理方法基于碎片的药物发现.的化合物的化合物蛋白质 - 配体相互作用基于结构的药物发现.

更多相关视频

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...